NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced the publication of a paper by Sapko, et. al. in the ...
Within three days, the patient reported “flushing, chills, confusion, urinary retention, dysuria, agitation, paranoia, anxiety, and auditory/visual hallucinations of humming and persons in his home” ...